|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by/(used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Noncash lease expense | |||||
| Stock-based compensation | |||||
| Deferred income tax expense (benefit) | |||||
| Charitable Contribution | |||||
| Gain related to the Charitable Contribution | |||||
| Contingent consideration fair value adjustments | |||||
| Other investment gains | |||||
| Net (gains) losses within CIPs | |||||
| Net (purchases) proceeds within CIPs | |||||
| (Earnings) losses from equity method investees | |||||
| Distributions of earnings from equity method investees | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Investments, trading | |||||
| Other assets | |||||
| Accrued compensation and benefits | |||||
| Accounts payable and accrued liabilities | |||||
| Other liabilities | |||||
| Net cash provided by/(used in) operating activities | |||||
| Investing activities | |||||
| Purchases of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Distributions of capital from equity method investees | |||||
| Net consolidations (deconsolidations) of sponsored investment funds | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of property and equipment | |||||
| Net cash provided by/(used in) investing activities | |||||
| Financing activities | |||||
| Repayments of long-term borrowings | |||||
| Proceeds from long-term borrowings | |||||
| Cash dividends paid | |||||
| Proceeds from stock options exercised | |||||
| Repurchases of common stock | |||||
| Net proceeds from (repayments of) borrowings by CIPs | |||||
| Net (redemptions/distributions paid)/subscriptions received from noncontrolling interest holders | |||||
| Other financing activities | |||||
| Net cash provided by/(used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase/(decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest | |||||
| Income taxes (net of refunds) | |||||
| Supplemental schedule of noncash investing and financing transactions: | |||||
| Issuance of common stock | |||||
| Charitable Contribution of an investment | |||||
| Increase/(decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds | |||||
Loading...